Delivery Order SPE2DR25D3005-SPE2DR26FP7EV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Tolvaptan 15 mg tablets in unit-dose packaging (10 count). This is a firm fixed-price delivery order with a ceiling value of $12,218.27 and an ultimate completion date of October 31, 2025. The contract represents a non-set-aside, competitively awarded procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packaging (10-count). The contract carries a ceiling value of $181,808 under a firm fixed-price arrangement with a completion date of July 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Tolvaptan 30 mg tablets in unit-dose packaging of 10 units, with a ceiling value of $18,283.30. The award, issued on October 24, 2025, utilizes firm fixed-price pricing with an ultimate completion date of October 27, 2025. This is a non-set-aside competitive award with performance at AmerisourceBergen's Conshohocken, Pennsylvania location, and the delivery order is structured as a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packages of 10 units. This is a firm fixed-price delivery order with a ceiling value of $5,100.87 and an ultimate completion date of July 18, 2025. The contract was awarded on a competitive basis without any set-aside designation. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packaging on September 9, 2025. This competitively awarded, non-set-aside contract is valued at $15,578.98 and requires completion by September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, under a firm fixed-price arrangement typical of delivery orders against existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Tolvaptan 30 mg tablets in unit dose packaging of 10s. This contract is a non-set-aside, competitively awarded delivery order with firm fixed pricing, valued at $48,454.20, with a completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $6,690.07 to AmerisourceBergen Drug Corp for Tolvaptan 15 mg tablets in unit dose packaging. This non-competitive delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price transaction for pharmaceutical supply. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $22,092.55 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit dose packaging (10-count units). This firm fixed price contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $33,218.27 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit dose packages of 10. This is a firm fixed price, competitively awarded contract with no set-aside designation, issued on June 16, 2025, with an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $15,233.64 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packaging of 10s. This non-set-aside contract was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed price pricing and represents a child delivery order issued under a...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7EVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Tolvaptan 15 mg tablets in unit-dose packaging of 10 units. This competitive award, valued at $44,199.07 on a firm fixed-price basis, is scheduled for completion by November 17, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement that extends through December 2026 and serves as a comprehensive vehicle for pharmaceutical and medical supply distribution to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this requirement as part of its extensive portfolio supporting Defense Health Agency and other government healthcare programs. The company's federal procurement history demonstrates consistent capability in delivering diverse pharmaceutical products through competitively awarded, non-set-aside contracts with DLA. This delivery order for Tolvaptan—a medication used primarily in the treatment of hyponatremia—aligns with AmerisourceBergen's established role as a primary supplier of specialty and therapeutic medications to military and federal healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.2k | 11/14/25 |